A Study of the Efficacy and Safety of WXSH0102 in Treating VCC Patients

NCT06771063 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
108
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Cisen Pharmaceutical CO., LTD.